MORGAN STANLEY recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
Morgan Stanley has its roots in the early to mid-1900s, tracing back to the history of JP Morgan & Co. and the Dean Witter brokerage house. The firm opened its doors in 1935, growing and going through a major restructuring in 1941 to allow for further expansion. In 1962, Morgan Stanley would create one of the first computer models for financial analysis. From then on the company would expand nationally and internationally, opening an office in Paris by 1967 and in Tokyo by 1970 and acquiring other companies through its Mergers & Acquisitions division in 1971. In 1984, Morgan Stanley would develop the first automated trade processing system, going public in 1986 as the company required more capital for growth. It would continue to expand globally, establishing the Morgan Stanley International Foundation in 1995. In 1997, it would merge with Dean, Witter, Discover & Co., creating the world’s largest securities firm. As the firm continued to hold a dominant role in innovative technologies, underwriting many large global tech IPOs, it would become the top ranked globally in equity trading and underwriting in 2004 under the lead of Phil Purcell. In 2008, Morgan Stanley would become a bank holding company, continuing to acquire companies such as Smith Barney from CitiGroup. Morgan Stanley’s subsidiaries are split into three groups: the Institutional Securities Group, which provides financial advisory and services in equity activities, fixed income securities, and related products; Wealth Management, which includes brokerage and investment advisory services; and Investment Management, which provides investment strategies. Some of its notable mutual funds include the S&P Financials Select Index and some of its ETFs include the S&P 500 SPDR and iShares Core. Morgan Stanley currently operates in 42 countries, having 1300 offices and 60 thousand employees that manage its over $800 billion in total assets.
As of the latest 13F report, the guru’s equity portfolio contained 7731 stocks valued at a total of $769.56Bil. The top holdings were MSFT(3.40%), AAPL(3.24%), and AMZN(1.66%).
According to GuruFocus data, these were MORGAN STANLEY’s top five trades of the quarter.
Blackrock Ltd Duration Income Trust
During the quarter, MORGAN STANLEY bought 322,421 shares of NYSE:BLW for a total holding of 3,634,912. The trade had a 0% impact on the equity portfolio. During the quarter, the stock traded for an average price of $12.1.
On 10/27/2022, Blackrock Ltd Duration Income Trust traded for a price of $12.31 per share and a market cap of $439.61Mil. The stock has returned -22.00% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 2 out of 10.
In terms of valuation, Blackrock Ltd Duration Income Trust has a price-book ratio of 0.91.
The price-to-GF Value ratio is 1.15, earning the stock a GF Value rank of 3.
10x Genomics Inc
During the quarter, MORGAN STANLEY bought 1,444,877 shares of NAS:TXG for a total holding of 10,341,753. The trade had a 0.01% impact on the equity portfolio. During the quarter, the stock traded for an average price of $32.99.
On 10/27/2022, 10x Genomics Inc traded for a price of $26.77 per share and a market cap of $3.05Bil. The stock has returned -83.16% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, 10x Genomics Inc has a price-book ratio of 3.89, a EV-to-Ebitda ratio of -25.45 and a price-sales ratio of 6.13.
The price-to-GF Value ratio is 0.24, earning the stock a GF Value rank of 2.
GoodRx Holdings Inc
MORGAN STANLEY reduced their investment in NAS:GDRX by 18,423,590 shares. The trade had a 0.01% impact on the equity portfolio. During the quarter, the stock traded for an average price of $6.1.
On 10/27/2022, GoodRx Holdings Inc traded for a price of $5.12 per share and a market cap of $2.04Bil. The stock has returned -87.93% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 4 out of 10.
In terms of valuation, GoodRx Holdings Inc has a price-book ratio of 2.49, a EV-to-Ebitda ratio of 25.07 and a price-sales ratio of 2.68.
Social Capital Suvretta Holdings Corp III
The guru established a new position worth 10,000,000 shares in NAS:DNAC, giving the stock a 0.01% weight in the equity portfolio. Shares traded for an average price of $9.28 during the quarter.
On 10/27/2022, Social Capital Suvretta Holdings Corp III traded for a price of $9.28 per share and a market cap of $295.94Mil. The stock has returned -6.92% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Social Capital Suvretta Holdings Corp III has a price-earnings ratio of 9999.00 and a price-sales ratio of 6.73.
Clough Global Equity Fund
During the quarter, MORGAN STANLEY bought 279,664 shares of AMEX:GLQ for a total holding of 2,002,938. The trade had a 0% impact on the equity portfolio. During the quarter, the stock traded for an average price of $8.79.
On 10/27/2022, Clough Global Equity Fund traded for a price of $6.93 per share and a market cap of $127.98Mil. The stock has returned -44.80% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 4 out of 10.
In terms of valuation, Clough Global Equity Fund has a price-book ratio of 0.68.
The price-to-GF Value ratio is 0.10, earning the stock a GF Value rank of 2.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
